Fundraising Fox

The Innovation Space β€” 2022 Investments

6 investments dated 2022 Β· listed companies and verified rows first Β· show all

Amalgentamalgent.cominApr 2022

Amalgent is a clinical-stage pain management company developing oral combination drug therapeutics that repurpose existing medications to improve the safety of severe pain treatment.

BiotechHealthtechChapel Hill, US

Malcolm A Meyn(Executive Officer, Director)Sam Tetlow(Co-founder, President & Executive Chair)inMalcolm Meyn(Co-founder & Chief Scientific Officer)Gerald(Chief Medical Officer)Andrew(Chief Finance Officer)in

Carbon Reformcarbonreform.comOct 2022

Philadelphia, US

Joanne Norris(Executive Officer, Director)Nick Martin(Executive Officer, Director)Jo Norris(Cofounder)

BoardAmy Duffuor(Director)in

Co-investorsAzolla VenturesGaingelsPlug and Play VenturesRise of the Rest Seed

Endoshuntendoshunt.cominNov 2022

EndoShunt develops a catheter-based device to control hemorrhage in traumatic vascular injuries, featuring a length-adjustable occlusion zone, temporary deployment, and an atraumatic tip.

HardwareHealthtechMedical DevicesLincoln, US

Michael Finn-Henry(President and Member of Board of Directors)inJeremy Levin(Director)

BoardMilad Behbahaninia(Member of Board of Directors)Olivia Busk(Member of Board of Directors)

Co-investorsNew York AngelsOcterra Capital

Ledaleda.coin𝕏Mar 2022

Leda provides self-administered DNA testing kits and related services for individuals who have experienced sexual assault, aiming to improve evidence collection and support for survivors.

HealthtechImpact & Social GoodBrooklyn, US

Liesel Vaidya(Executive Officer, Director)Madison Campbell(Executive Officer, Director)

Co-investors2B.VCCalm/Storm VCHypothesisStone Mountain VenturesGaingelsHelm+1 more

OncoXomeoncoxome.comDec 2022

Oncoxome develops an oral delivery platform for cancer therapies that targets tumor cells directly with minimal off-target toxicity.

BiotechDeep TechMedical DevicesNorth Hollywood, US

Auriane Gamelin(Executive Officer, Director)Laurence Gamelin(Executive Officer, Director)Erick Gamelin(Executive Officer, Director)

Versogenversogen.comin𝕏Apr 2022

Versogen develops anion exchange membrane (AEM) electrolyzers that produce green hydrogen at scale for decarbonizing the energy, chemical, and manufacturing sectors.

CleantechClimate TechEnergyWilmington, US

Yushan Yan(CEO and Co-Founder)inJunhua Wang(Chief Scientist and Co-Founder)Lan Wang(China Market Manager and Co-Founder)inBrian Setzler(Senior Chemical Engineer and Co-Founder)inKeda Hu(Senior Chemist and Co-Founder)inBalsu Lakshmanan(Chief Technology Officer)in

Co-investorsPangaea Ventures Us Inc.TechEnergy Ventures

Rows marked β€œSEC filing” are inferred from directors named on the company's SEC Form D β€” public regulatory data, not a portfolio list published by the firm.